PA
EFC

PharVision Advisers’s Ellington Financial EFC Stock Holding History

PharVision Advisers’s Portfolio EFC Stock Details EFC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Buy
+14,267
New +$181K 1.72% 6

Other funds holding EFC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DFG
Delphi Financial Group Wilmington, Delaware $222M AUM 11.28% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's EFC Position: Q1 2026 in Review

PharVision Advisers opened a new position in Ellington Financial (EFC) in Q1 2026: 14,267 shares worth $169K. The stake represents 1.72% of the portfolio and ranks #6 among its holdings.

237 funds tracked by Wall St. Rank hold EFC as of Q1 2026.

  • PharVision Advisers held 14,267 shares of Ellington Financial worth $169K as of Q1 2026.
  • Ellington Financial was a new PharVision Advisers position in Q1 2026.
  • Ellington Financial made up 1.72% of PharVision Advisers's portfolio in Q1 2026, its #6 holding.
  • 237 funds tracked by Wall St. Rank held Ellington Financial as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.